Clinical Trial Update: Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and pharmacokinetics of AKB-6548 in adults with CKD (stages 3-4) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• AKB-6548

Snippet

Sponsor: Akebia Therapeutics | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-05-17